Monday’s Highlights at Noon: ImmunoCellular Therapeutics (IMUC), Anthera Pharmaceuticals (ANTH), Ebix Inc (EBIX), Advaxis (ADXS), Fuelcell Energy (FCEL)

By Carrie Williams

So far Monday, June 17, NASDAQ is up 2.13% and the S&P is up 0.32%. Here are this morning’s most active stocks: ImmunoCellular Therapeutics (IMUCResearch Report), Anthera Pharmaceuticals (ANTHResearch Report), Ebix Inc (EBIXResearch Report), Advaxis (ADXSResearch Report) and Fuelcell Energy (FCELResearch Report).

ImmunoCellular Therapeutics is up 18.24% in midday trading to $0.02. Shares opened today at $0.02. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

Anthera Pharmaceuticals is up 17.93% in midday trading to $0.06. Shares opened today at $0.05. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

Ebix Inc is down -14.29% in midday trading to $45.65. Shares opened today at $53.26. The company has a 52-week low of $39.27 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $95.50, marking a 79.31% potential upside from current levels. In a report issued on May 13, BMO analyst James Fotheringham maintained a Hold rating on EBIX, with a price target of $67, which represents a potential upside of 26% from where the stock is currently trading. Separately, on May 9, Maxim Group’s Allen Klee maintained a Buy rating on the stock and has a price target of $124. Over the last 3 months, the insider sentiment on Ebix Inc has been negative based on 13 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Advaxis is down -11.74% in midday trading to $2.17. Shares opened today at $2.46. The company has a 52-week low of $2.08 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $5.15, marking a 109.35% potential upside from current levels. In a report issued on June 12, H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Hold rating on ADXS, with a price target of $4.30, which represents a potential upside of 75% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Advaxis has been positive based on 13 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Fuelcell Energy is down -11.37% in midday trading to $0.31. Shares opened today at $0.35. The company has a 52-week low of $0.20 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.00, marking a 183.53% potential upside from current levels. In a report issued on June 6, Oppenheimer analyst Colin Rusch downgraded FCEL to Hold.

Trending Stocks Based on Insider Activity >>